{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:05:31Z","timestamp":1791223531030,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1016\/j.vaccine.2005.11.040","type":"journal-article","created":{"date-parts":[[2005,12,6]],"date-time":"2005-12-06T12:20:52Z","timestamp":1133871652000},"page":"2290-2301","source":"Crossref","is-referenced-by-count":53,"title":["Development and evaluation of a Shigella flexneri 2a and S. sonnei bivalent invasin complex (Invaplex) vaccine"],"prefix":"10.1016","volume":"24","author":[{"given":"Edwin V.","family":"Oaks","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. Ross","family":"Turbyfill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2005.11.040_bib1","first-page":"651","article-title":"Global burden of Shigella infections: implications for vaccine development and implementation of control strategies","volume":"77","author":"Kotloff","year":"1999","journal-title":"Bull World Health Organ"},{"issue":"6","key":"10.1016\/j.vaccine.2005.11.040_bib2","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1086\/317500","article-title":"Transient increase in diarrheal diseases after the devastating earthquake in Kocaeli, Turkey: results of an infectious disease surveillance study","volume":"31","author":"Vahaboglu","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2005.11.040_bib3","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1086\/427501","article-title":"Gastroenteritis in US Marines during Operation Iraqi Freedom","volume":"40","author":"Thornton","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"9359","key":"10.1016\/j.vaccine.2005.11.040_bib4","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0140-6736(03)12644-X","article-title":"Shigella dysenteriae type 1 with reduced susceptibility to fluoroquinolones","volume":"361","author":"Sarkar","year":"2003","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.vaccine.2005.11.040_bib5","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1086\/516303","article-title":"Trends in antibiotic resistance among diarrheal pathogens isolated in Thailand over 15 years","volume":"26","author":"Hoge","year":"1998","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2005.11.040_bib6","doi-asserted-by":"crossref","first-page":"5168","DOI":"10.1128\/IAI.62.11.5168-5172.1994","article-title":"Construction and characterization of attenuated (delta)aroA (delta)virG Shigella flexneri 2a strain CVD 1203, a prototype live oral vaccine","volume":"62","author":"Noriega","year":"1994","journal-title":"Infect Immun"},{"issue":"Suppl. 4","key":"10.1016\/j.vaccine.2005.11.040_bib7","doi-asserted-by":"crossref","first-page":"S285","DOI":"10.1093\/clinids\/13.Supplement_4.S285","article-title":"Genetic and molecular basis of epithelial cell invasion by Shigella species","volume":"13","author":"Sansonetti","year":"1991","journal-title":"Rev Infect Dis"},{"issue":"21\u201322","key":"10.1016\/j.vaccine.2005.11.040_bib8","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1016\/S0264-410X(03)00111-7","article-title":"Protective efficacy of oral immunization with heat-killed Shigella flexneri 2a in animal model: study of cross protection, immune response and antigenic recognition","volume":"21","author":"Mukhopadhaya","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.11.040_bib9","doi-asserted-by":"crossref","unstructured":"McKenzie R, Walker RI, Nabors GS, Van de Verg L, Carpenter C, Gomes G, et al. Safety and immunogenicity of an oral, inactivated, whole-cell vaccine for Shigella sonnei: preclinical studies and a Phase I trial. Vaccine, doi:10.1016\/j.vaccine.2005.07.014.","DOI":"10.1016\/j.vaccine.2005.07.014"},{"issue":"2","key":"10.1016\/j.vaccine.2005.11.040_bib10","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1651-2227.1999.tb01075.x","article-title":"Killed oral Shigella vaccine made from Shigella flexneri 2a protects against challenge in the rabbit model of shigellosis","volume":"88","author":"Chakrabarti","year":"1999","journal-title":"Acta Paediatr"},{"issue":"6","key":"10.1016\/j.vaccine.2005.11.040_bib11","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1128\/IAI.61.6.2390-2395.1993","article-title":"Immunogenicity and efficacy of oral or intranasal Shigella flexneri 2a and Shigella sonnei proteosome-lipopolysaccharide vaccines in animal models","volume":"61","author":"Orr","year":"1993","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.11.040_bib12","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0140-6736(96)06255-1","article-title":"Double-blind vaccine-controlled randomised efficacy trial of an investigational Shigella sonnei conjugate vaccine in young adults","volume":"349","author":"Cohen","year":"1997","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.vaccine.2005.11.040_bib13","doi-asserted-by":"crossref","first-page":"3610","DOI":"10.1128\/IAI.59.10.3610-3618.1991","article-title":"Protective ribosomal preparation from Shigella sonnei as a parenteral candidate vaccine","volume":"59","author":"Levenson","year":"1991","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.11.040_bib14","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1086\/515150","article-title":"Rupture of the intestinal epithelial barrier and mucosal invasion by Shigella flexneri","volume":"28","author":"Sansonetti","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2005.11.040_bib15","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1128\/IAI.67.7.3437-3443.1999","article-title":"Vaccination against Shigellosis with attenuated Shigella flexneri 2a strain SC602","volume":"67","author":"Coster","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.11.040_bib16","doi-asserted-by":"crossref","first-page":"6624","DOI":"10.1128\/IAI.68.12.6624-6632.2000","article-title":"Isolation and characterization of a Shigella flexneri invasin complex subunit vaccine","volume":"68","author":"Turbyfill","year":"2000","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2005.11.040_bib17","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1128\/IAI.53.1.57-63.1986","article-title":"Serum immune response to Shigella protein antigens in Rhesus monkeys and humans infected with Shigella spp.","volume":"53","author":"Oaks","year":"1986","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2005.11.040_bib18","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1128\/IAI.18.1.94-98.1977","article-title":"Detection and differentiation of iron-responsive avirulent mutants on Congo red agar","volume":"18","author":"Payne","year":"1977","journal-title":"Infect Immun"},{"issue":"11","key":"10.1016\/j.vaccine.2005.11.040_bib19","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1128\/IAI.56.11.2933-2941.1988","article-title":"Shigella flexneri invasion plasmid antigens B and C: epitope location and characterization with monoclonal antibodies","volume":"56","author":"Mills","year":"1988","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.11.040_bib20","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/0264-410X(93)90016-Q","article-title":"Evaluation of Shigella vaccine safety and efficacy in an intranasally challenged mouse model","volume":"11","author":"Mallett","year":"1993","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2005.11.040_bib21","doi-asserted-by":"crossref","first-page":"4075","DOI":"10.1128\/IAI.59.11.4075-4083.1991","article-title":"Small-animal model to measure efficacy and immunogenicity of Shigella vaccine strains","volume":"59","author":"Hartman","year":"1991","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2005.11.040_bib22","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.femsre.2003.07.002","article-title":"Shigella flexneri infection: pathogenesis and vaccine development","volume":"28","author":"Jennison","year":"2004","journal-title":"FEMS Microbiol Rev"},{"issue":"2","key":"10.1016\/j.vaccine.2005.11.040_bib23","first-page":"89","article-title":"Construction of a stable and non-resistant bivalent vaccine candidate strain against Shigella flexneri 2a and Shigella sonnei","volume":"12","author":"Rui","year":"1996","journal-title":"Chin J Biotechnol"},{"issue":"4","key":"10.1016\/j.vaccine.2005.11.040_bib24","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1006\/mpat.1996.0061","article-title":"Towards a vaccine candidate against Shigella dysenteriae 1: expression of the Shiga toxin B-subunit in an attenuated Shigella flexneri aroD carrier strain","volume":"21","author":"Tzschaschel","year":"1996","journal-title":"Microb Pathog"},{"key":"10.1016\/j.vaccine.2005.11.040_bib25","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1006\/mpat.1996.0127","article-title":"Construction and characterization of genetically-marked bivalent anti-Shigella dysenteriae 1 and anti-Shigella flexneri Y live vaccine candidates","volume":"22","author":"Klee","year":"1997","journal-title":"Microb Pathog"},{"key":"10.1016\/j.vaccine.2005.11.040_bib26","doi-asserted-by":"crossref","first-page":"4572","DOI":"10.1128\/IAI.66.9.4572-4576.1998","article-title":"Construction of a stable attenuated Shigella sonnei deltavirG vaccine strain, WRSS1, and protective efficacy and immunogenicity in the guinea pig keratoconjunctivitis model","volume":"66","author":"Hartman","year":"1998","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.vaccine.2005.11.040_bib27","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/0264-410X(89)90160-6","article-title":"Construction and evaluation of a double mutant of Shigella flexneri as a candidate for oral vaccination against shigellosis","volume":"7","author":"Sansonetti","year":"1989","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2005.11.040_bib28","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1128\/IAI.70.6.2950-2958.2002","article-title":"Construction, characterization, and animal testing of WRSdl, a Shigella dysenteriae 1 vaccine","volume":"70","author":"Venkatesan","year":"2002","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2005.11.040_bib29","first-page":"457","article-title":"Studies on vaccination against bacillary dysentery. 6. Protection of children by oral immunization with streptomycin-dependent Shigella strains","volume":"45","author":"Mel","year":"1971","journal-title":"Bull World Health Organ"},{"issue":"4","key":"10.1016\/j.vaccine.2005.11.040_bib30","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2165\/00148581-200406040-00004","article-title":"Meningococcal vaccines","volume":"6","author":"Ruggeberg","year":"2004","journal-title":"Paediatr Drugs"},{"issue":"1","key":"10.1016\/j.vaccine.2005.11.040_bib31","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1086\/375536","article-title":"Safety and immunogenicity of a bivalent group B streptococcal conjugate vaccine for serotypes II and III","volume":"188","author":"Baker","year":"2003","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2005.11.040_bib32","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1128\/IAI.70.4.2171-2177.2002","article-title":"Immunogenicity of a 26-valent group A streptococcal vaccine","volume":"70","author":"Hu","year":"2002","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.vaccine.2005.11.040_bib33","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1001\/jama.292.6.709","article-title":"Safety and immunogenicity of a recombinant multivalent group a streptococcal vaccine in healthy adults: phase 1 trial","volume":"292","author":"Kotloff","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2005.11.040_bib34","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1093\/infdis\/164.3.533","article-title":"Effect of prior infection with virulent Shigella flexneri 2a on the resistance of monkeys to subsequent infection with Shigella sonnei","volume":"164","author":"Formal","year":"1991","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2005.11.040_bib35","doi-asserted-by":"crossref","first-page":"569","DOI":"10.3109\/00365549309008545","article-title":"Serum antibody responses against Shigella lipopolysaccharides and invasion plasmid-coded antigens in Shigella infected Swedish patients","volume":"25","author":"Li","year":"1993","journal-title":"Scand J Infect Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2005.11.040_bib36","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.1128\/IAI.63.10.3927-3935.1995","article-title":"Recognition of three epitopic regions on invasion plasmid antigen C by immune sera of Rhesus monkeys infected with Shigella flexneri 2a","volume":"63","author":"Turbyfill","year":"1995","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.11.040_bib37","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1128\/IAI.63.6.2382-2386.1995","article-title":"Intranasal or intragastric immunization with proteosome-Shigella lipopolysaccharide vaccines protects against lethal pneumonia in a murine model of Shigella infection","volume":"63","author":"Mallett","year":"1995","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.11.040_bib38","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1128\/iai.30.2.321-324.1980","article-title":"Protection against keratoconjunctivitis Shigellosa induced by immunization with outer membrane proteins of Shigella spp.","volume":"30","author":"Adamus","year":"1980","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.11.040_bib39","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1128\/AAC.42.6.1476","article-title":"Delivery of the non-membrane-permeative antibiotic gentamicin into mammalian cells by using Shigella flexneri membrane vesicles","volume":"42","author":"Kadurugamuwa","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.vaccine.2005.11.040_bib40","doi-asserted-by":"crossref","first-page":"566","DOI":"10.4049\/jimmunol.169.1.566","article-title":"Differential induction of mucosal and systemic antibody responses in women after nasal, rectal, or vaginal immunization: Influence of the menstrual cycle","volume":"169","author":"Kozlowski","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2005.11.040_bib41","doi-asserted-by":"crossref","unstructured":"Fries LF, Montemarano AD, Mallett CP, Taylor DN, Hale TL, Lowell GH. Safety and immunogenicity of a proteosome-Sbigella flexneri 2a lipopolysaccharide vaccine administered intranasally to healthy adults. Infect Immun 2001; 69:4545\u201353.","DOI":"10.1128\/IAI.69.7.4545-4553.2001"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X0501193X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X0501193X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T01:39:26Z","timestamp":1626831566000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X0501193X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":41,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["S0264410X0501193X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2005.11.040","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,3]]}}}